Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxine Sun

Showing results (391-400 of 401) with videos related to

Pageof 41
Sort By:
Cancer Cell|April 5, 2024
Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomesRenée Maria Saliby, Chris Labaki, Tejas R Jammihal, et al.
Nature Medicine|May 31, 2020
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinomaDavid A Braun, Yue Hou, Ziad Bakouny, et al.
Circulation. Genomic and Precision Medicine|February 9, 2021
Pharmacogenomics of the Efficacy and Safety of Colchicine in COLCOTMarie-Pierre Dubé, Marc-André Legault, Audrey Lemaçon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2026
Dissecting the Tumor Microenvironment to Identify Biomarkers of Outcome to Anti-PD-1 Therapy in Clear Cell Renal Cell Carcinoma: analyses of the HCRN GU16-260 trialNourhan El Ahmar, Morgan A Paul, Berkay Simsek, et al.
Cancer Cell|March 12, 2021
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinomaKevin Bi, Meng Xiao He, Ziad Bakouny, et al.
Cancer Cell|June 10, 2025
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinomaKevin Bi, Meng Xiao He, Ziad Bakouny, et al.
Scientific Reports|May 26, 2021
Genetics of symptom remission in outpatients with COVID-19Marie-Pierre Dubé, Audrey Lemaçon, Amina Barhdadi, et al.
Cancer Cell|March 12, 2021
Progressive immune dysfunction with advancing disease stage in renal cell carcinomaDavid A Braun, Kelly Street, Kelly P Burke, et al.
Nature Communications|February 6, 2021
Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinomaZiad Bakouny, David A Braun, Sachet A Shukla, et al.
European Heart Journal|March 22, 2021
Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortalityStefan J Schunk, Marcus E Kleber, Winfried März, et al.
Pageof 41

Showing results (391-400 of 401) with videos related to

Sort By:
Pageof 41
Cancer Cell|April 5, 2024
Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomesRenée Maria Saliby, Chris Labaki, Tejas R Jammihal, et al.
Nature Medicine|May 31, 2020
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinomaDavid A Braun, Yue Hou, Ziad Bakouny, et al.
Circulation. Genomic and Precision Medicine|February 9, 2021
Pharmacogenomics of the Efficacy and Safety of Colchicine in COLCOTMarie-Pierre Dubé, Marc-André Legault, Audrey Lemaçon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2026
Dissecting the Tumor Microenvironment to Identify Biomarkers of Outcome to Anti-PD-1 Therapy in Clear Cell Renal Cell Carcinoma: analyses of the HCRN GU16-260 trialNourhan El Ahmar, Morgan A Paul, Berkay Simsek, et al.
Cancer Cell|March 12, 2021
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinomaKevin Bi, Meng Xiao He, Ziad Bakouny, et al.
Cancer Cell|June 10, 2025
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinomaKevin Bi, Meng Xiao He, Ziad Bakouny, et al.
Scientific Reports|May 26, 2021
Genetics of symptom remission in outpatients with COVID-19Marie-Pierre Dubé, Audrey Lemaçon, Amina Barhdadi, et al.
Cancer Cell|March 12, 2021
Progressive immune dysfunction with advancing disease stage in renal cell carcinomaDavid A Braun, Kelly Street, Kelly P Burke, et al.
Nature Communications|February 6, 2021
Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinomaZiad Bakouny, David A Braun, Sachet A Shukla, et al.
European Heart Journal|March 22, 2021
Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortalityStefan J Schunk, Marcus E Kleber, Winfried März, et al.
Pageof 41